相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 20002004
Candace H. Feldman et al.
ARTHRITIS AND RHEUMATISM (2013)
Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes
L. A. Gonzalez et al.
LUPUS (2013)
Abatacept in B7-1-Positive Proteinuric Kidney Disease
Chih-Chuan Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
European genetic ancestry is associated with a decreased risk of lupus nephritis
Ilana B. Richman et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Abatacept for lupus nephritis Alternative definitions of complete response support conflicting conclusions
David Wofsy et al.
ARTHRITIS AND RHEUMATISM (2012)
Lupus in Hispanics: A matter of serious concern
Guillermo J. Pons-Estel et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2012)
CD28-B7 Interaction Modulates Short- and Long-Lived Plasma Cell Function
Modesta N. Njau et al.
JOURNAL OF IMMUNOLOGY (2012)
American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Bevra H. Hahn et al.
ARTHRITIS CARE & RESEARCH (2012)
CD28 Expressed on Malignant Plasma Cells Induces a Prosurvival and Immunosuppressive Microenvironment
Jayakumar R. Nair et al.
JOURNAL OF IMMUNOLOGY (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
F. A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Nizar J. Bahlis et al.
BLOOD (2007)
A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE
Monica Fernandez et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial
Joel M. Kremer et al.
ANNALS OF INTERNAL MEDICINE (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2004)
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition
L Schiffer et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
GG Illei et al.
ANNALS OF INTERNAL MEDICINE (2001)
Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
DI Daikh et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
TM Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
